ArticleMissouri medicine
AI for Scientific Discovery in Omics Data-Driven Precision Medicine.
Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Graph in Graph (GiG): A novel graph AI framework for integrating and interpreting medical and omics data.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In recent years, the rapid advancement of high-throughput technologies has led to the generation of vast and complex multi-omics datasets that are valuable for characterizing and understanding complex cell signaling network systems. On the other hand, large language models (LLMs), domain-specific foundation models (FMs) and AI agents, have achieved significant breakthroughs and have been revolutionizing scientific research. The convergence of these two trends is catalyzing a new era for biomedical research to augment and speed up scientific discovery and the development of precision medicine. In this study, we examine the large-scale omics datasets, emerging applications, and challenges at the intersection of massive omic datasets and related AI models and agents, highlighting how their integration is reshaping the landscape of biomedical research and precision medicine.
Indexed as
Identifiers
41742924PMC12931591What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.